InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by 1315 Capital II, L.P.. Director active across 1 company, notably Interpace Biosciences, INC.. Aggregated, 1 disclosures have been published. History available since 20 January 2026. The latest transaction was filed on 20 January 2026 (C). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration